Telbivudine versus Entecavir in Patients with Chronic Hepatitis B: 2-Year Results of a Head-To-Head Trial

被引：0
|
作者：
Huang, Jing [1 ]
Chen, Xiaoping [1 ]
Chen, Xuefu [1 ]
Chen, Re [1 ]
Chen, Wenli [1 ]
Ma, Xiaojun [1 ]
Luo, Xiaodan [1 ]
机构：
[1] Guangdong Acad Med Sci, Guangdong Gen Hosp, Guangzhou, Guangdong, Peoples R China
来源：
HEPATOLOGY | 2013年 / 58卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
983
引用
收藏
页码：681A / 681A
页数：1
相关论文
共 50 条
  • [31] Telbivudine globe trial at year two: Efficacy, safety, and predictors of outcome in patients with chronic hepatitis B
    Han, Steven-Huy
    Lai, Ching Lung
    Gane, Edward J.
    Liaw, Yun-Fan
    Thongsawar, Satawat
    Wang, Yuming
    Chen, Yagang
    Heathcote, E. Jenny
    Rasenack, Jens
    Bzowej, Natalie
    Naoumov, Nikolai V.
    Brown, Nathaniel A.
    GASTROENTEROLOGY, 2007, 132 (04) : A765 - A765
  • [32] First Results of a Head-to-Head Trial of Acalabrutinib vs Ibrutinib in Previously Treated Chronic Lymphocytic Leukemia
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2021, 19 (07) : 2 - 4
  • [33] Comparison of the Effects of Telbivudine and Entecavir Treatment on Estimated Glomerular Filtration Rate in Patients with Chronic Hepatitis B
    Lee, Sangheun
    Park, Jun Yong
    Song, Kijun
    Kim, Do Young
    Kim, Beom Kyung
    Kim, Seung Up
    Ku, Hye Jin
    Han, Kwang-Hyub
    Ahn, Sang Hoon
    GUT AND LIVER, 2015, 9 (06) : 776 - 783
  • [34] COST COMPARISON OF ABATACEPT AND ADALIMUMAB BASED ON AMPLE, A 2-YEAR HEAD-TO-HEAD OUTCOMES STUDY IN RHEUMATOID ARTHRITIS
    Gaultney, J.
    Budd, D.
    Nappi, C.
    Benucci, M.
    Iannazzo, S.
    Alemao, E.
    Sabater, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 551 - 552
  • [35] A HEAD-TO-HEAD COMPARISON OF PEGINTERFERON α-2B TREATMENT REGIMENS IN THE TREATMENT OF CHINESE AND SOUTH-EAST ASIAN PATIENTS WITH HBEAG POSITIVE CHRONIC HEPATITIS B
    Fan, Xiaoling
    Wang, Yuming
    Luo, Duande
    Hou, Jinlin
    Huang, Zhenfei
    Zhang, Ye
    Xu, Dao-Zhen
    Cheng, Jun
    HEPATOLOGY, 2010, 52 (04) : 386A - 386A
  • [36] A 1-year trial of telbivudine, lamivudine, and the combination in patients with hepatitis B e antigen-positive chronic hepatitis B
    Lai, CL
    Leung, N
    Teo, EK
    Tong, M
    Wong, F
    Hann, HW
    Han, S
    Poynard, T
    Myers, M
    Chao, G
    Lloyd, D
    Brown, NA
    GASTROENTEROLOGY, 2005, 129 (02) : 528 - 536
  • [37] Long-term outcome of telbivudine versus entecavir in treating higher viral load chronic hepatitis B patients without cirrhosis
    Pan, H. -Y.
    Pan, H. -Y.
    Song, W. -Y.
    Zheng, W.
    Tong, Y. -X.
    Yang, D. -H.
    Dai, Y. -N.
    Chen, M. -J.
    Wang, M. -S.
    Huang, Y. -C.
    Zhang, J. -J.
    Huang, H. -J.
    JOURNAL OF VIRAL HEPATITIS, 2017, 24 : 29 - 35
  • [38] Tenofovir monotherapy versus tenofovir and entecavir combination therapy in patients with entecavir-resistant chronic hepatitis B with multiple drug failure: results of a randomised trial
    Lim, Young-Suk
    Byun, Kwan Soo
    Yoo, Byung Chul
    Kwon, So Young
    Kim, Yoon Jun
    An, Jihyun
    Lee, Han Chu
    Lee, Yung Sang
    GUT, 2016, 65 (05) : 852 - 860
  • [39] A one-year trial of entecavir treatment in patients with HBeAg-positive chronic hepatitis B
    Fen-Yu Ren
    World Journal of Gastroenterology, 2007, (31) : 4264 - 4267
  • [40] Efficacy and safety of entecavir versus tenofovir treatment in chronic hepatitis B patients: A randomized controlled trial
    Sriprayoon, Tassanee
    Mahidol, Chulabhorn
    Ungtrakul, Teerapat
    Chun-on, Pattra
    Soonklang, Kamonwan
    Pongpun, Wanvisa
    Laohapand, Charlie
    Dechma, Jiraporn
    Pothijaroen, Charinthip
    Auewarakul, Chirayu
    Tanwandee, Tawesak
    HEPATOLOGY RESEARCH, 2017, 47 (03) : E161 - E168
12345